At a glance
ClinicalIndex Comparison Record- ✓Age 60 to 90 years
- ✓Undergoing evaluation for possible Alzheimer's disease
- ✓Severity ranges from mild cognitive impairment to mild dementia
- ✓Diagnosis of either suspected typical AD or atypical AD based on referring neurologist
- ✕Moderate to severe dementia
- ✕Active delirium per neurologist's determination
- ✕Legally blind or deaf
- ✕Brain tumor
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Integrating Home-Based Video Teleneuropsychology Into Clinical Practice: Typical Versus Atypical Alzheimer's Disease
In Brief
A clinical study evaluating Face-to-face evaluation (FF) and TeleNP evaluation for Suspected Typical Alzheimer's Disease (AD) and Suspected Atypical Alzheimer's Disease (AD). Completed, enrolled 116 participants across 1 site.
Detailed Summary
The overarching goal of this study is to a) assess the feasibility and preliminary validity of home-based delivery of TeleNP to patients with suspected Alzheimer's Disease (AD), referred for cognitive assessments in a Neurology Clinic; and b) elucidate whether TeleNP is equivalent to face-to-face evaluation (FF) for diagnostic adjudication of atypical versus typical AD.
Study Details
Timeline
Interventions
The intervention is the assessment modality. The control condition is face-to-face evaluation (FF).
The intervention is the assessment modality. The intervention condition is TeleNP evaluation.